A comprehensive view of Respiratory / Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
CHMP recommends EU approval of Roche’s Alecensa as the first adjuvant treatment for resected ALK-positive early-stage lung cancer
Published:
April 26, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Media Update: New data presented at ATS demonstrate Sanofi’s leadership in advancing potential new therapies for patients with immune-mediated respiratory diseases
Published:
April 26, 2024
by Sanofi SA
|
BRISTOL MYERS SQUIBB CO - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 25, 2024
by SEC Edgar Filings
|
European Patent Office Publishes Eli Lilly and Company's Patent Application for 2019 Novel Coronavirus Antibody-Containing Pharmaceutical Formulations
Published:
April 25, 2024
by Pharmaceutical Patent News
|
Moderna To present respiratory & cytomegalovirus research at the ESCMID Global Congress
Published:
April 25, 2024
by Moderna Inc.
|
Ask us about our Government & Public Policy market view